Back to FDA Applications sponsored by MERCK

FDA Drug Application 062756 by MERCK

Application Number062756
Application Type Abbreviated New Drug Application
Sponsor ApplicantMERCK
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type
Therapeutic Potential
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP01/8/1987N       
AP03/7/1991SL18496003   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S003_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP02/26/1991SC18495004   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S004_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP012/29/1993SL17517005   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf 8/6/2007
AP09/9/1991SC18494006   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S006_ADD_PRIMAXIN_VANTAGE.pdf 11/19/2007
AP012/29/1993SL17518007   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf 8/6/2007
AP012/29/1993SL17519008   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf 8/6/2007
AP09/9/1991SCX18493009   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S009_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP012/29/1993SLI17520010   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf 8/6/2007
AP07/12/1995SL18060011   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN 9/26/2007
AP02/18/1992SCI18063012   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S012_PRIMAXIN ADD-VANTAGE.pdf 9/26/2007
AP02/18/1992SC18064013   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S013_PRIMAXIN ADD-VANTAGE.pdf 9/26/2007
AP02/3/1993SLI18065014   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S014_PRIMAXIN ADD-VANTAGE.pdf 9/26/2007
AP08/31/1992SC18066015   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S015_PRIMAXIN ADD-VANTAGE.pdf 9/26/2007
AP07/12/1995SL18061017   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN 9/26/2007
AP010/11/1996SLI18067018   http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf 9/26/2007
AP07/12/1995SLI18062019   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN 9/26/2007
AP09/2/1994SC17871020   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S020_PRIMAXIN ADD-VANTAGE.pdf 9/13/2007
AP05/9/1995SC18070021   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S021_PRIMAXIN ADD-VANTAGE.pdf 9/26/2007
AP010/11/1996SL18068022   http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf 9/26/2007
AP04/30/1997SL18071023   http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/062756_S023_PRIMAXIN.pdf 9/26/2007
AP08/31/2001SL18492024   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S024_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP05/8/1996SC18072025   http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S025_PRIMAXIN I.V.pdf 9/26/2007
AP010/11/1996SL18069026   http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf 9/26/2007
AP010/31/1996SC18073027   http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S027_PRIMAXIN I.V.pdf 9/26/2007
AP03/17/1998SL18074028   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/062756_S028_PRIMAXIN.pdf 9/26/2007
AP01/28/1999SL18075029   http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/062756_S029_PRIMAXIN.pdf 9/26/2007
AP011/29/1999SC18076030   http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/062756_S030_PRIMAXIN.pdf 9/26/2007
AP08/31/2001SL       
AP09/10/2001SCR18491032   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S032_PRIMAXIN_I.V._VANTAGE.pdf 11/19/2007
AP010/11/2001SCB18489033   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S033&S034_PRIMAXIN_VANTAGE.pdf 11/19/2007
AP010/11/2001SCS18490034   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S033&S034_PRIMAXIN_VANTAGE.pdf 11/19/2007
AP04/19/2002SCB18488035   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S035_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP08/20/2002SL18487037   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S037_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP010/17/2002SCP18486038   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S038_PRIMAXIN_ADD_VANTAGE.pdf 11/19/2007
AP04/23/2010SLR       




Back to FDA Applications sponsored by MERCK

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.